Emergent BioSolutions filed an 8-K saying its CEO will present slides at a Sept 14 conference. The filing only furnishes an investor presentation and adds no new financial figures, so it does not change the company's outlook.
Emergent filed an 8-K saying its CEO will present slides at an investor conference on Sept 14. The filing furnishes an investor presentation but gives no new financial numbers, so I read it as neutral for EBS.
Follow Emergent BioSolutions Inc. (EBS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for EBS